This time on The Other Side of the Table, I sit down with Lazar Bojic from Curie Bio, whose work is instrumental in helping biotech founders keep control of their companies while getting the support they need.

Lazar shares Curie’s unique model that helps startups save on two big expenses—people and lab space—so founders can focus on the science without giving away too much equity too soon. We also take a detailed look into today’s biotech investment scene, the importance of solid clinical data, and how Curie guides startups from fundraising to hiring.

Lazar’s advice on pitching, building a team, and navigating the market is a must-hear for anyone raising funds in biotech.

Come and join us!

On this episode, I chat with Jason Mellad, CEO of Start Codon, about the Biotech investment market and startup success.

Jason talked about the importance of strong, adaptable teams in early-stage companies and offers plenty of practical advice on understanding the market, recognising weaknesses, and trying to continuously improve. He shared the most common fundraising mistakes he sees, and the things that turn him off as an investor.

Jason is always great value, and the advice he gave in this interview was no exception. Come listen for the masterclass you might just need...

Pam Garside is an experienced angel investor and Chair of Cambridge Angels, one of the UK's leading investor networks.

On this epsiode of The Other Side of The Table, we sat down with Pam to discuss the importance of smart money, why tenacity, boldness and perserverance are critical traits for founders, and her top tips on your investment deck.

Enjoy!